Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prediction of Lymphatic Metastasis in Esophageal Cancer by CT Radiomics

NCT03237130 is registered in ClinicalTrials.gov with Peking University Cancer Hospital & Institute as lead sponsor.

NCT NCT03237130
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03237130 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prediction of Lymphatic Metastasis in Esophageal Cancer by CT Radiomics
Lead sponsor
Peking University Cancer Hospital & Institute
Phase
Observational
Overall status
Completed
Start date
February 15, 2017
Completion date
May 15, 2020
Enrollment
133 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

esophagus cancer